Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel RFA Panel; Understanding Chronic Conditions Understudied Among Women.                    

*Date:*                         December 13, 2024.                    

*Time:*                         9:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Amy Kathleen Wernimont, Ph.D.,  Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6198, Bethesda, MD 20892, 301-827-6427,                         *amy.wernimont@nih.gov.*

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; Topics in Bacterial-Host Interactions.                    

*Date:*                         December 13, 2024.                    

*Time:*                         10:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Bakary Drammeh, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 805-P, Bethesda, MD 20892, (301) 435-0000,                         *drammehbs@csr.nih.gov.*

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; Member Conflict: Topics in Disease Control and Applied Immunology.                    

*Date:*                         December 13, 2024.                    

*Time:*                         10:00 a.m. to 7:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Jui Pandhare, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-7735,                         *pandharej2@csr.nih.gov.*

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; Small Business: Topics in Microbial Diagnostics and Anti-Infective Prevention Measures.                    

*Date:*                         December 13, 2024.                    

*Time:*                         12:30 p.m. to 6:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Bidyottam Mittra, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20894, (301) 435-4057,                         *bidyottam.mittra@nih.gov.*

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; Topics in Health Services Research.                    

*Date:*                         December 18, 2024.                    

*Time:*                         3:00 p.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Angela D. Thrasher, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1000J, Bethesda, MD 20892, (301) 480-6894,                         *thrasherad@csr.nih.gov.*

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; Member Conflict: Topics in HIV Virology, Immunopathogenesis, and Drug/Vaccine Development.                    

*Date:*                         December 18, 2024.                    

*Time:*                         12:00 p.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Kenneth M Izumi, Ph.D., Scientific Review Officer, NIH Center for Scientific Review, 6701 Rockledge Drive, MSC 7808, Bethesda, MD 20892, 301-496-6980,                         *izumikm@csr.nih.gov.*

This notice is being published less than 15 days from the meetings' dates due to exceptional circumstances. The technical and scientific peer review of applications assigned to the above meetings must take place urgently so that review evaluations of biomedical research applications addressing multiple major public health priorities, including women's health research, may be submitted to the national advisory councils to make timely funding recommendations. If the meetings are not held on the December 13, 2024 and December 18, 2024 dates, committee members with the requisite scientific expertise will be unable to attend due to unresolvable scheduling conflicts. The result would be a 6-9 month delay in funding and a profound negative impact on health-related research.
      ( print page 100518)    
(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

Dated: December 9, 2024. 

Lauren A. Fleck, 

Program Analyst,  Office of Federal Advisory Committee Policy.

[FR Doc. 2024-29269 Filed 12-11-24; 8:45 am]

BILLING CODE 4140-01-P